Business Wire

Lofted Custom Spirits Launches Alternating Proprietorship Program

Share

Lofted Custom Spirits, the nation’s first and leading custom contract whiskey distiller, today announced the launch of a new Alternating Proprietorship program, allowing partners to take advantage of significantly reduced excise tax rates. Using their own DSP license and Lofted’s dedicated processing facility, craft brands can get the full benefit of Craft Beverage Modernization Act (CBMA) tax breaks and save an average $6 per proof gallon.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804995682/en/

Under current CBMA rules, only DSPs that perform processing activities beyond bottling—such as manufacturing, blending, filtering, or flavor addition—can claim the lower federal excise tax rate on up to 100,000 proof gallons annually. Lofted Custom Spirits’ Alternating Proprietorship opens the door to TTB-compliant tax savings not available through other Kentucky contract distillers.

“Lofted Custom Spirits built this program like we’ve built our business – on a foundation of true partnership, operational integrity, the utmost quality and strict compliance. This foundation of trust means that our clients can pour their energy into building great brands, not consumed by process and regulation,” said Mark Erwin, CEO of Lofted Spirits, the parent company of Lofted Custom Spirits, Bardstown Bourbon Company and Green River Distilling Co.

In a newly outfitted processing facility, the Lofted Custom Spirits will continue to provide hands-on support and labor under the client’s DSP license, ensuring seamless operation and continuity.

“We’ve worked closely with the TTB to bring this offering on board in a way that ensures operational effectiveness and full compliance with the industry regulations. As with every expansion we’ve made, we’ve created this program in the spirit of true partnership with the brands that trust us to keep their whiskey brand flowing,” said Erwin.

The Alternating Proprietorship is available now for both existing and new clients. For more information, visit LoftedSpirits.com.

ABOUT LOFTED SPIRITS

From bespoke bourbon production to boundary-pushing brands, Lofted Spirits is where tradition meets transformation. Expanding on the work started by Peter Loftin in 2016, and today the number one producer of Kentucky contract whiskey, Lofted Spirits pioneered a world-class, industry-shaking approach to custom contract distillation while developing some of the fastest growing brands in American Whiskey, Bardstown Bourbon and Green River. A unified entity, Lofted Spirits is built to lead the global whiskey industry, delivering exceptional experiences through innovation, trust and transformative industry impact while crafting some of the world’s most desired and awarded whiskies. Lofted Spirits joined the Pritzker Private Capital family of companies in 2022. Learn more at LoftedSpirits.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250804995682/en/

Contacts

Media Contact:
Holly Weyler
hweyler@loftedspirits.com
502.836.8715

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution15.12.2025 14:05:00 CET | Press Release

Novotech, a leading global full-service clinical research organization (CRO) and scientific advisory company, has released a new white paper, Early-Phase Oncology – Clinical Research Landscape and CRO Enablers (2025), offering in-depth analysis of the key drivers shaping early-phase oncology development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215843975/en/ With approximately 60% of oncology agents progressing from Phase I to Phase II, but only 3–6% reaching regulatory approval, the paper outlines the factors influencing early-stage success, including trial design, patient selection, and regional development pathways. The paper highlights Australia’s continued position as a global first-in-human (FIH) and early-phase research hub. Its ethics-led review frameworks, which can support trial initiation within roughly 4–8 weeks, combined with established FIH centers, oncology networks, and cost efficiencies, position Au

Ant Group Announces Major Upgrades to Its 15-Million-MAU AI Health App AQ Amid Wider Push into Health Sector15.12.2025 14:03:00 CET | Press Release

Ant Group today announced major upgrades to its AI health app AQ, with a new Chinese name “Ant A-Fu.” The character “Fu” conveys good wishes and well-being, reflecting the app’s goal to promote better health and quality of life. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215203213/en/ Ant Group’s AI health app AQ features three core capabilities: health Q&A, AI health companion, and integrated health services. The upgraded version of AQ now features three core capabilities: health Q&A, AI health companion, and integrated health services. Launched in June 2025, AQ has rapidly grown to 15 million monthly active users, making it China’s leading AI health management app. Positioned as an AI health companion service, AQ currently answers over 5 million health-related questions every day. The announcement comes amid China’s ongoing demographic shift. According to projections from the National Health Commission, by around 20

Copeland and Daikin Cooperation Brings Solutions to European Customers15.12.2025 14:00:00 CET | Press Release

Copeland and Daikin, two global leaders in heating, ventilation and air conditioning (HVAC) solutions, today announced the expansion of their existing joint venture into Europe. Through this cooperation, the companies will introduce advanced inverter swing rotary compressors, power electronics and controls designed specifically for European residential heat pumps. This collaboration underscores both companies’ commitment to accelerate the energy transition, with heat pumps recognized by industry reports as a cornerstone technology helping to reduce global carbon dioxide emissions by an estimated 500 million tons by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215625806/en/ (Left to right) Ross B. Shuster, CEO of Copeland and Jiro Tomita, executive associate officer of Daikin As Europe rapidly transitions away from fossil fuels, the demand for residential heat pumps is growing in parallel with ambitious sustainabil

Visa Unveils New Global Stablecoins Advisory Practice15.12.2025 13:00:00 CET | Press Release

Visa (NYSE: V), a global leader in digital payments, today announced the launch of its Stablecoins Advisory Practice. The new value-added service offering by Visa Consulting & Analytics (VCA) provides actionable insights and recommendations to guide banks, fintechs, merchants, and businesses of all sizes on market fit, strategy, and implementation. As the stablecoin market cap surpasses $250 billion, Visa’s settlement volume has accelerated, reaching a $3.5 billion annualized run rate as of November 30. Businesses are turning to Visa’s new Stablecoins Advisory Practice to unlock growth opportunities. “Putting our members first has always been our mission, and we’re committed to exploring innovations that strengthen financial health and convenience for those we serve. Stablecoins may represent an opportunity to enhance speed and lower cost in payments, so with the support of Visa, we are evaluating how this technology could fit into our broader strategy to deliver meaningful value to ou

SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion15.12.2025 12:30:00 CET | Press Release

SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values the Company in excess of EUR €1.5 billion. Swixx is the global leader in rest-of-world pharmaceutical commercialization services dedicated to delivering innovative, life-saving medications to underserved and hard-to-reach markets. Stuart Swanson and Petr Němec, Swixx’s Co-Founders, and Jean-Michel Lespinasse and Petr Pipal, Swixx’s CEO and CFO, respectively, will all retain significant ownership stakes in Swixx as part of the transaction. Existing institutional investors HBM Healthcare Investments, a Swiss-listed investment company for the global healthcare market, and Mérieux Equity Partners, a leading healthcare-specializ

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye